US Patent 9828635 Predicting tumor response to anti-ERBB3 antibodies
Patent 9828635 was granted and assigned to AVEO Pharmaceuticals on November, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9828635 Predicting tumor response to anti-ERBB3 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
